Lin Shao-Lee 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Lin Shao-Lee（CIK 1725092）在 1 家公司共报告 8 笔 SEC Form 4 内部人交易（最近一笔 2026-08-14）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-14 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | 买入 | 109,179 | $0 |
| 2026-08-14 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | 卖出 | 34,225 | $923,733 |
| 2026-08-14 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | 卖出 | 5,775 | $160,256 |
| 2026-08-14 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | 卖出 | 5,423 | $147,451 |
| 2026-08-14 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | 卖出 | 2,375 | $66,761 |
| 2026-08-14 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | 卖出 | 10,460 | $308,361 |
| 2026-07-10 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | 买入 | 327,537 | $0 |
| 2026-05-07 | Cue Biopharma, Inc. (CUE) | CHIEF EXECUTIVE OFFICER | 买入 | 327,537 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-08-14